Venook AP - Search Results

1

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer.

Ko AH, Hwang J, Venook AP, Abbruzzese JL, Bergsland EK, Tempero MA. Ko AH, et al. Among authors: venook ap. Br J Cancer. 2005 Jul 25;93(2):195-9. doi: 10.1038/sj.bjc.6602687. Br J Cancer. 2005. PMID: 15999098 Free PMC article. Clinical Trial.

2

A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma.

Wilkinson MJ, Frye JW, Small EJ, Venook AP, Carroll PR, Ernest ML, Stagg RJ. Wilkinson MJ, et al. Among authors: venook ap. Cancer. 1993 Jun 1;71(11):3601-4. doi: 10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#. Cancer. 1993. PMID: 8490909 Clinical Trial.

3

Hepatocellular carcinoma.

Bergsland EK, Venook AP. Bergsland EK, et al. Among authors: venook ap. Curr Opin Oncol. 2000 Jul;12(4):357-61. doi: 10.1097/00001622-200007000-00013. Curr Opin Oncol. 2000. PMID: 10888422 Review.

4

Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.

Venook AP, Egorin MJ, Rosner GL, Hollis D, Mani S, Hawkins M, Byrd J, Hohl R, Budman D, Meropol NJ, Ratain MJ. Venook AP, et al. J Clin Oncol. 2000 Jul;18(14):2780-7. doi: 10.1200/JCO.2000.18.14.2780. J Clin Oncol. 2000. PMID: 10894879 Clinical Trial.

5

Shedding old paradigms: developing viruses to treat cancer.

Bergsland EK, Venook AP. Bergsland EK, et al. Among authors: venook ap. J Clin Oncol. 2002 May 1;20(9):2220-2. doi: 10.1200/JCO.2002.20.9.2220. J Clin Oncol. 2002. PMID: 11980991 No abstract available.

6

Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer.

Mehta KR, Nakao K, Zuraek MB, Ruan DT, Bergsland EK, Venook AP, Moore DH, Tokuyasu TA, Jain AN, Warren RS, Terdiman JP, Waldman FM. Mehta KR, et al. Among authors: venook ap. Clin Cancer Res. 2005 Mar 1;11(5):1791-7. doi: 10.1158/1078-0432.CCR-04-1418. Clin Cancer Res. 2005. PMID: 15756001

7

Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma.

Venook AP. Venook AP. Cancer. 2005 Jun 15;103(12):2435-46. doi: 10.1002/cncr.21123. Cancer. 2005. PMID: 15880563 Free article. Review.

8

Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas.

Ko AH, Dito E, Schillinger B, Venook AP, Bergsland EK, Tempero MA. Ko AH, et al. Among authors: venook ap. J Clin Oncol. 2006 Jan 20;24(3):379-85. doi: 10.1200/JCO.2005.01.8267. Epub 2005 Dec 12. J Clin Oncol. 2006. PMID: 16344320 Clinical Trial.

9

Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma.

Venook AP, Blanke CD, Niedzwiecki D, Lenz HJ, Taylor JR, Hollis DR, Sutherland S, Goldberg RM. Venook AP, et al. Clin Colorectal Cancer. 2005 Nov;5(4):292-4. doi: 10.3816/ccc.2005.n.043. Clin Colorectal Cancer. 2005. PMID: 16356309 Clinical Trial. No abstract available.

10

Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.

Kulke MH, Bergsland EK, Ryan DP, Enzinger PC, Lynch TJ, Zhu AX, Meyerhardt JA, Heymach JV, Fogler WE, Sidor C, Michelini A, Kinsella K, Venook AP, Fuchs CS. Kulke MH, et al. Among authors: venook ap. J Clin Oncol. 2006 Aug 1;24(22):3555-61. doi: 10.1200/JCO.2006.05.6762. J Clin Oncol. 2006. PMID: 16877721 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

325 results

Search Page